Biopharmaceuticals
Cardiology
News Release - March 26, 2007
ACUITY One-Year Findings Meet All Primary Endpoints in Favor of Angiomax(R) (Bivalirudin) Alone Treatment Group
Source: The Medicines Company
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.